Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
88 EUR | -0.45% |
|
-1.57% | -4.56% |
2023 | Lebon: appointment of a CSR Director | CF |
2023 | Compagnie Lebon Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
Strengths
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- For several months, analysts have been revising their EPS estimates roughly upwards.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
Ratings chart - Surperformance
Sector: Investment Management & Fund Operators
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-4.56% | 115M | - | ||
+1.42% | 121B | A- | ||
+6.28% | 98.23B | C+ | ||
+14.54% | 68.39B | - | B+ | |
+27.92% | 67.83B | C | ||
+17.65% | 45.39B | C+ | ||
+16.10% | 43.76B | A- | ||
+23.59% | 36.91B | A- | ||
+10.07% | 25.92B | B | ||
-1.16% | 22.74B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- ALBON Stock
- 88J Stock
- Ratings Compagnie Lebon